Developing new, affordable vaccines for the people who need them most

Vaccines are one of the most effective, affordable, and beneficial tools in public health. Because market forces alone are not always strong enough to drive the development of vaccines most urgently needed in lower-income countries, PATH’s Vaccine Development Global Program is stepping in to fill the gap. Find out more »

---

Rotavirus vaccine developed in India demonstrates strong efficacy The Government of India’s Department of Biotechnology and vaccine manufacturer Bharat Biotech announced positive results from a Phase 3 clinical trial of a rotavirus vaccine developed and manufactured in India through an international social innovation partnership that includes PATH.  Read the press release and supporting materials »

Highlights new initiative:  PATH helps garner support for integrated action plan on pneumonia and diarrhea » video: Zambia is taking action against diarrhea in five integrated ways. Watch how! » blog:  Dr. Mark Alderson offers a pneumonia perspective on child survival. Read the Q&A » update: PATH signs onto polio eradication declaration » event: Don’t miss the RSV Vaccines for the World conference October 14 to 16 in Portugal! Submit abstracts today »

---

Sign up for our e-newsletter

Our e-newsletter, Vaccines for the Future, provides quarterly updates on our efforts to develop innovative, safe, effective, and affordable vaccines. It includes updates on our progress, partnerships, and specific activities. Sign up now »

---

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) seeks to gather the world’s best immunization resources in a single, easy-to-use website. The VRL offers high-quality, scientifically accurate documents and links on specific diseases and topics in immunization. Learn more »

---

Banner photos, clockwise from left: Philippe Blanc; PATH/Chutima Suraratdecha; Richard Franco.